AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 NOV 3 - (NewsRx.com & NewsRx.net) -- GenoMed, Inc., (GMED) announced that it will offer its patent-pending broad spectrum viral antidote to the U.S. during the coming flu season this fall and winter.
Because of difficulties that a major pharmaceutical company has experienced at a British factory, nearly half of the flu vaccine doses destined for the U.S. will not be delivered in time for this year's flu season.
U.S. health authorities have already begun planning how to ration existing flu vaccine doses.
GenoMed has applied for patent protection on the use of a class of blood pressure medications in viral diseases, such as the flu. This is a totally novel approach. There is no shortage of these medications worldwide.
The company has had 100% success in treating a small number of normal, immunocompetent patients ...